Across cohorts, we found that Rubicon was expressed at low levels in control biopsies and was upregulated in chronic ABMR (CABMR), SLE, and RA in regions colocalizing with ECs (Ulex) bound by complement (C4d, C6, Fig. 6d–f). This evidence concerns the gene RUBCN and rheumatoid arthritis.